Asgerdur Sverrisdottir

ESMO National Representative in Iceland

Term 2016 – 2017
Address Department of Medical Oncology

Landspitali University Hospital
101 Reykjavik


Asgerdur Sverrisdottir, MD, PhD, is a specialist in Medical and Radiation Oncology.

She graduated from the University of Iceland in 1989 and did her specialist training in Oncology at Karolinska University Hospital in Stockholm, Sweden. She achieved a specialist degree in Oncology in 1998 and worked at Karolinska Hospital in the fields of breast cancer and lymphomas until 2005. Since then she has been working at the Department of Medical Oncology at Landspitali University Hospital, Reykjavik, Iceland, specialising in the field of breast cancer. Dr. Sverrisdottir is the leading oncologist in genito-urinary oncology at Landspitali and she is also a leading oncologist in supervising electronic medical chemotherapy systems in Iceland.

In 2012 she achieved a PhD degree from Karolinska Institutet, Stockholm, Sweden, with the thesis “Adjuvant Tamoxifen and Luteinizing Hormone-Releasing Hormone Agonists in Premenopausal Breast Cancer: on long-term benefits and side effects in a randomised study”.

From 2010 to 2014 she chaired the Nordic Cancer Union Scientific Committee in Iceland, a committee that she firstly joined in 2008 as a member. She is currently the Chairman of the Icelandic Society of Clinical Oncology, the Vice Chair of the Steering Committee of Reykjavik Cancer Society and a member of the Steering Committee of the Icelandic Cancer Society Scientific Fund.

She has been a PI for multiple clinical trials, both investigator initiated and pharmaceutical sponsored studies, in the fields of breast cancer, kidney cancer, prostate cancer and lymphomas, in Stockholm and Iceland. She has chaired a GCP-course in Iceland and is the author of several clinical guidelines for the use of novel therapies at Landspitali.

Her main interests in oncology lie in the field of endocrine treatment, targeted therapy, young patients, fertility issues, bone health and long-term side effects.